ライフサイエンスコーパス: fluid-attenuated inversion recovery

1 inium-enhanced T1-weighted, T2-weighted, and fluid-attenuated inversion recovery).

2 imaging and a higher reliance on T2-weighted fluid-attenuated inversion recovery.

3 The three-dimensional fluid-attenuated inversion recovery (3D-FLAIR) sequence

4 (c) Axial fluid-attenuated inversion recovery (6000/120) MRI and (

5 ctron microscopy in FIB-SEM dataset, and (4) Fluid attenuated inversion recovery abnormality from MR

6 Manual segmentation of T2-fluid attenuated inversion recovery and diffusion weight

7 Whole-brain, 2-dimensional, fluid-attenuated inversion recovery and 3-dimensional, m

8 ared as hyperintense regions on T2-weighted, fluid-attenuated inversion recovery and diffusion-weight

9 Structural changes identified with fluid-attenuated inversion recovery and diffusion-weight

10 ing microhemorrhages and hyperintensities on fluid-attenuated inversion recovery and diffusion-weight

11 white matter hyperintense lesions seen with fluid-attenuated inversion recovery and diffusion-weight

12 dical records and magnetic resonance imaging fluid-attenuated inversion recovery and gradient-echo sc

13 Brain magnetic resonance imaging using fluid-attenuated inversion recovery and high-resolution

14 Fluid-attenuated inversion recovery and magnetization tr

15 cts and cerebral microbleeds was assessed on fluid-attenuated inversion recovery and T1-weighted and

16 High-spatial-resolution fluid-attenuated inversion recovery and T2*-weighted ima

17 ion leading to transient hyperintensities on fluid-attenuated inversion recovery and T2-weighted sequ

18 Brain MRI was performed with 3D T1-weighted, fluid-attenuated inversion-recovery and T2-weighted sequ

19 three-dimensional (3D) T1 precontrast, 3D T2 fluid-attenuated inversion recovery, and 3D T1 postcontr

20 on transfer MRI, diffusion-weighted imaging, fluid-attenuated inversion recovery, and contrast-enhanc

21 ceptibility-weighted perfusion, T2-weighted, fluid-attenuated inversion recovery, and high-dose contr

22 rative T1-weighted, T2-weighted, T2-weighted fluid-attenuated inversion recovery, and postcontrast T1

23 re- and postcontrast transverse T1-weighted, fluid-attenuated inversion recovery, and T2-weighted ima

24 g T1-weighted, T2-weighted, T2*-weighted, T2 fluid-attenuated inversion-recovery, and diffusion-weigh

25 imaging revealed diffusion-weighted imaging+/fluid-attenuated inversion recovery- and diffusion-weigh

26 s emphasising the value of three dimensional-fluid-attenuated inversion recovery as the core brain pu

27 on recovery- and diffusion-weighted imaging+/fluid-attenuated inversion recovery+ asymptomatic lesion

28 mor MRI indices at baseline (tumor volume on fluid-attenuated inversion recovery, baseline intratumor

29 duced diffusion and high signal intensity on fluid-attenuated inversion recovery brain MRI within a v

30 ensional (3D) isotropic contrast-enhanced T2 fluid-attenuated inversion recovery (CE-T2-FLAIR) imagin

31 new hyperintensity on diffusion-weighted and fluid-attenuated inversion recovery cerebral MRI sequenc

32 with pathological MRI-signal (by T2-weighted Fluid-Attenuated Inversion Recovery) crossing the midlin

33 onal and fast spin echo T2-weighted imaging, fluid-attenuated inversion recovery, detection of blood-

34 T1- and T2-weighted, fluid-attenuated inversion recovery, diffusion- and perf

35 biased, whole-brain analyses on T1-weighted, fluid-attenuated inversion recovery, diffusion-weighted

36 n CT, or MRI with diffusion weighted imaging-fluid attenuated inversion recovery (DWI-FLAIR) mismatch

37 of post-contrast T1-weighted and T2-weighted fluid attenuated inversion recovery (FLAIR) image data i

38 s using T1-contrast enhancing (T1-CE) and T2-Fluid attenuated inversion recovery (FLAIR) magnetic res

39 cally ill cats, which included multifocal T2 fluid attenuated inversion recovery (FLAIR) signal hyper

40 T2 weighted, T1 fluid attenuated inversion recovery (FLAIR), T2 FLAIR, s

41 s) or regions that were only hyperintense on fluid-attenuated inversion recovery (FLAIR) 1H images (e

42 scanners, with T1-weighted, T2-weighted, and fluid-attenuated inversion recovery (FLAIR) acquisitions

43 -prepared rapid acquisition gradient echoes, fluid-attenuated inversion recovery (FLAIR) and fluid an

44 s study, a secondary analysis of T2-weighted fluid-attenuated inversion recovery (FLAIR) and T1-weigh

45 Images were displayed with T2-weighting or fluid-attenuated inversion recovery (FLAIR) contrast.

46 tney U test), (d) relationships between fast fluid-attenuated inversion recovery (FLAIR) data and enh

47 )-based diffusion-weighted imaging (DWI) and fluid-attenuated inversion recovery (FLAIR) estimates le

48 Conclusion Synthetic fluid-attenuated inversion recovery (FLAIR) had diagnost

49 eta-analysis to determine the association of fluid-attenuated inversion recovery (FLAIR) hyperintense

50 colorations in cm-thick brain slices were T2/fluid-attenuated inversion recovery (FLAIR) hyperintense

51 MRI findings including T2 or fluid-attenuated inversion recovery (FLAIR) hyperintensi

52 ial intelligence (AI) on clinical-quality T2-fluid-attenuated inversion recovery (FLAIR) images alone

53 normal, hyperintense, rarefied, or cystic on fluid-attenuated inversion recovery (FLAIR) images and c

54 rain ratio (VBR) was measured on T2-weighted fluid-attenuated inversion recovery (FLAIR) images at di

55 signal evolution on magnetic resonance (MR) fluid-attenuated inversion recovery (FLAIR) images betwe

56 erial-enhanced, T1-weighted nonenhanced, and fluid-attenuated inversion recovery (FLAIR) images in 18

57 ted images, postcontrast T1-weighted images, fluid-attenuated inversion recovery (FLAIR) images, and

58 n-echo (SSFSE) and echo-planar imaging (EPI) fluid-attenuated inversion recovery (FLAIR) images, and

59 ion-weighted imaging (Figs 1-3), T2-weighted fluid-attenuated inversion recovery (FLAIR) imaging (Fig

60 -state acquisition (FIESTA), and T2-weighted fluid-attenuated inversion recovery (FLAIR) imaging were

61 These are best evaluated with fluid-attenuated inversion recovery (FLAIR) imaging; the

62 enhanced histogram equalization grayscale of fluid-attenuated inversion recovery (FLAIR) in a brain i

63 Background In acute ischemic stroke (AIS), fluid-attenuated inversion recovery (FLAIR) is used for

64 between diffusion-weighted imaging (DWI) and fluid-attenuated inversion recovery (FLAIR) magnetic res

65 layer appearance of the cerebral cortex with fluid-attenuated inversion recovery (FLAIR) magnetic res

66 of ischemic stroke patients screened for DWI-fluid-attenuated inversion recovery (FLAIR) mismatch in

67 l sulcal hyperintensities (IFSH) observed on fluid-attenuated inversion recovery (FLAIR) MRI have bee

68 euroradiologists independently reviewed 2572 fluid-attenuated inversion recovery (FLAIR) MRI scans fr

69 The fluid-attenuated inversion recovery (FLAIR) sequence for

70 Background The T2-weighted fluid-attenuated inversion recovery (FLAIR) sequence is

71 ent with a conventional two-dimensional (2D) fluid-attenuated inversion recovery (FLAIR) sequence wit

72 Evaluation of tumor measurements and fluid-attenuated inversion recovery (FLAIR) sequences we

73 niques like 3D T1-weighted, T2-weighted, and fluid-attenuated inversion recovery (FLAIR) sequences, M

74 ith gradual magnetic resonance imaging (MRI) fluid-attenuated inversion recovery (FLAIR) signal (sub-

75 hanced tumor volume, noncontrast-enhanced T2 fluid-attenuated inversion recovery (FLAIR) signal abnor

76 formed 1 month earlier had revealed five new fluid-attenuated inversion recovery (FLAIR) T2-hyperinte

77 nces - T1-weighted (T1W), T2-weighted (T2W), fluid-attenuated inversion recovery (FLAIR), diffusion-w

78 nds in brain imaging are reviewed, including fluid-attenuated inversion recovery (FLAIR), diffusion-w

79 t commonly used MRI sequences, which are T2, fluid-attenuated inversion recovery (FLAIR), double inve

80 ched patients without MS, sagittal 2-mm fast fluid-attenuated inversion-recovery (FLAIR) imaging was

81 performed to measure tumor volumes based on fluid-attenuated inversion-recovery (FLAIR) imaging.

82 t SE, gradient-echo and SE (GRASE), and fast fluid-attenuated inversion-recovery (FLAIR) imaging.

83 ted supra- and infratentorially on simulated fluid-attenuated inversion-recovery (FLAIR) magnetic res

84 ee-dimensional (3D) fast spin-echo (FSE) and fluid-attenuated inversion-recovery (FLAIR) T2-weighted

85 data during a comprehensive, multicontrast (fluid-attenuated inversion recovery [FLAIR] and T1-, T2-

86 methods (T1- and T2-weighted MR imaging plus fluid-attenuated inversion recovery [FLAIR] at 3-mm sect

87 inium-enhanced T1-weighted, T2-weighted, and fluid-attenuated inversion recovery [FLAIR] images) were

88 ced images (double inversion recovery [DIR], fluid-attenuated inversion recovery [FLAIR]) and contras

89 nnel inputs (T1, T2, and T1 postcontrast and fluid-attenuated inversion recovery [FLAIR]) was trained

90 cm, 15 of 18), subcortical (18 of 18), T2 or fluid-attenuated inversion recovery hyperintense (18 of

91 Fluid-attenuated inversion recovery hyperintense areas w

92 e imaging revealed more frequent thalamic T2 fluid-attenuated inversion recovery hyperintensities in

93 es revealed confluent bifrontal white matter fluid-attenuated inversion recovery hyperintensities, as

94 38 (39.5%) patients, mostly white matter T2/fluid-attenuated inversion recovery hyperintensities.

95 sets with a volume resolution of 1 mm(3) and fluid-attenuated inversion-recovery image sets with a vo

96 MH volume was quantified from T2-weighted or fluid-attenuated inversion recovery images or as hypoint

97 , a deep learning approach using T2-weighted fluid-attenuated inversion recovery images was developed

98 MRI fluid-attenuated inversion recovery images were segmente

99 quantified using combined T1-weighted and T2-fluid-attenuated inversion recovery images.

100 lesions were segmented semiautomatically on fluid-attenuated inversion recovery images.

101 ions and hyperintense regions at nonenhanced fluid-attenuated inversion recovery imaging) information

102 tiple sclerosis patients using post-contrast fluid-attenuated inversion recovery imaging, early trial

103 (contrast material-enhanced T1-weighted and fluid-attenuated inversion-recovery imaging sequences) a

104 the posterior pole that were hyperintense at fluid-attenuated inversion-recovery imaging.

105 e veins draining toward the dural sinuses on fluid-attenuated inversion recovery in subjects with Alz

106 weighted imaging lesions and a corresponding fluid-attenuated inversion recovery lesion 48 hours afte

107 te models including brain GM and WM volumes, fluid-attenuated inversion recovery lesion load, T1 lesi

108 esion number, brain WM volumes, brain T1 and fluid-attenuated inversion recovery lesion loads, age, s

109 story of optic neuritis, was associated with fluid-attenuated inversion recovery lesion volume (P=.00

110 sification task, namely the detection of new fluid-attenuated inversion recovery lesions at MRI durin

111 eatment; P < .02), and mean number of new T2/fluid-attenuated inversion recovery lesions per year (7.

112 3D T2-Fluid Attenuated Inversion Recovery magnetic resonance i

113 g white matter tissue lesions in T2-weighted fluid attenuated inversion recovery magnetic resonance i

114 Automated assessment of supratentorial fluid-attenuated inversion recovery magnetic resonance h

115 High-resolution T1-weighted and T2-weighted-fluid-attenuated inversion recovery magnetic resonance i

116 ities and brain infarcts were measured using fluid-attenuated inversion recovery magnetic resonance i

117 Clinic Study of Aging who had a baseline 3 T fluid-attenuated inversion recovery magnetic resonance i

118 ical white matter hyperintensities (WMHs) on fluid-attenuated inversion recovery magnetic resonance i

119 ck, and definitive ischemic brain lesions on fluid-attenuated inversion recovery magnetic resonance i

120 reduction in the volume of cerebral edema on fluid-attenuated inversion recovery-magnetic resonance i

121 isotropic resolution magnetization-prepared, fluid-attenuated inversion recovery (MPFLAIR).

122 -weighted magnetic resonance (MR) images, or fluid-attenuated inversion-recovery MR images were obtai

123 ed with semiautomated volumetric analysis at fluid-attenuated inversion recovery MRI by readers who w

124 ee patients with FCD type IIB who had T1 and fluid-attenuated inversion recovery MRI data, the MELD F

125 The presence of fluid-attenuated inversion recovery MRI signal abnormali

126 lesions and overlaying them onto T2-weighted fluid-attenuated inversion recovery MRI-delineated tumor

127 (and metrics obtained) were: (i) optic nerve fluid-attenuated inversion-recovery (optic nerve cross-s

128 predicted outcomes with higher accuracy than fluid-attenuated inversion recovery or diffusion-weighte

129 formed 1 month earlier had revealed five new fluid-attenuated inversion recovery (or FLAIR) T2-hyperi

130 ighted gradient echo sequences combined with fluid attenuated inversion recovery, or saccades error r

131 ity-normalized T(1) -w (p-value = 0.011) and fluid-attenuated inversion recovery (p-value = 0.005).

132 Fluid attenuated inversion recovery, post-contrast T(1)-

133 MR imaging was performed with fluid-attenuated inversion recovery, proton-density, T2-

134 Figure 1b: (a) Axial fluid-attenuated inversion recovery (repetition time mse

135 Figure 1c: (a) Axial fluid-attenuated inversion recovery (repetition time mse

136 Figure 1a: (a) Axial fluid-attenuated inversion recovery (repetition time mse

137 Figure 1d: (a) Axial fluid-attenuated inversion recovery (repetition time mse

138 compare STAIR-UTE and a clinical T2-weighted fluid-attenuated inversion recovery sequence for assessm

139 Conclusion The echo-planar fluid-attenuated inversion recovery sequence improves vi

140 with a coronal fat-saturated short echo fast fluid-attenuated inversion recovery sequence.

141 intense white matter abnormalities on T2 and fluid attenuated inversion recovery sequences predominan

142 , and/or susceptibility-weighted imaging and fluid-attenuated inversion recovery sequences, were cons

143 nenhancing component depicted on T2-weighted/fluid-attenuated inversion recovery sequences.

144 sequences (eg, T1-weighted, T2-weighted, and fluid-attenuated inversion-recovery sequences), but mult

145 nsional, spoiled gradient-recalled-echo; and fluid-attenuated inversion-recovery sequences.

146 ic resonance imaging showed increased T2 and fluid-attenuated inversion recovery signals in the putam

147 hted, postcontrast T1-weighted, T2-weighted, fluid-attenuated inversion recovery, susceptibility-weig

148 resolution multishell DWI, and 3-dimensional fluid-attenuated inversion recovery, T1, and susceptibil

149 fluid-attenuated inversion-recovery, T1-weighted, T1-wei

150 Patients with maximal T2-fluid attenuated inversion recovery (T2-FLAIR) resection

151 l dystrophy and patchy increased T2-weighted fluid-attenuated inversion recovery (T2/FLAIR) signal in

152 with diffusion-weighted MR imaging and with fluid-attenuated inversion recovery, T2-weighted fast sp

153 T) PET; 3-T MRSI with a short echo time; and fluid-attenuated inversion recovery, T2-weighted, and co

154 tical signal intensities within T1-weighted, fluid-attenuated inversion recovery, T2-weighted, and pr

155 ronic MS lesions on conventional T2-weighted fluid-attenuated inversion recovery, T2-weighted, and T1

156 uded sagittal T1-weighted images, axial fast fluid-attenuated inversion-recovery/T2-weighted images,

157 ned as Wahlund score >=4 points) detected by fluid-attenuated inversion recovery was present in 130 (

158 with contrast enhancement, T2 weighted, and fluid-attenuated inversion recovery) was performed.

159 cluding contrast-enhanced and T2-weighted or fluid-attenuated inversion recovery-weighted images) is